Max Robotics — Global Service Robot Directory + US Certification

About

Milly Buwenge is a leading researcher in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) and robotic radiosurgery for challenging cancers. Her major contributions center on improving symptom management and treatment precision, particularly in pancreatic and prostate cancers. Her most cited work, a 2018 systematic review on stereotactic radiotherapy for pancreatic cancer (64 citations), established SBRT as a key modality for pain relief in locally advanced pancreatic carcinoma, addressing a critical need for palliation in patients with poor prognosis. She further advanced this field with a 2015 systematic review on robotic radiosurgery in pancreatic cancer, evaluating single-fraction outcomes. Demonstrating her versatility, Buwenge is also pioneering the use of machine learning in radiation oncology, as seen in her 2025 multicenter ICAROS study, which developed a predictive model for acute toxicity in prostate cancer patients undergoing salvage radiotherapy. Additionally, her narrative review on CyberKnife in pediatric oncology highlights her commitment to reducing long-term radiation effects in vulnerable populations. With a growing portfolio spanning symptom palliation, toxicity prediction, and pediatric care, Buwenge’s work is shaping safer, more effective radiotherapy strategies.